Statistics for Dynavax Technologies (id:7698 DVAX)

Valuation metrics

Market cap

1.60B

Enterprise value

1.07B

Trailing P/E (ttm)

81.13

Forward P/E

33.81

PEG ratio

33.81

Price/Sales (ttm)

6.13

Price/Book (mrq)

2.35

Enterprise Value/Revenue

4.10

Enterprise Value/EBITDA

-658.88

Overview

Shares outstanding

131.46M

Float

113.20M

Shares short

18.84M

% Held by insiders

0.00%

% Held by institutions

1.04%

Average volume (10 days)

3.64M

Average volume (90 days)

Price summary

52-Week low

9.74

52-Week high

15.01

52-Week change

-11.42%

Beta

1.34

50-Day moving average

11.42

200-Day moving average

11.60

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 10th, 2014

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

7.85%

Operating margin

15.24%

Operational effectiveness

Return on assets

-0.38%

Return on equity

3.18%

Income statement

Revenue (ttm)

2.00

Revenue per share (ttm)

2.00

Quarterly revenue growth (yoy)

0.23

Gross profit (ttm)

182.12M

EBITDA

20.98M

Net income to common (ttm)

20.48M

Diluted EPS (ttm)

0.15

Quarterly earnings growth (yoy)

23.10%

Balance sheet

Total cash (mrq)

763.99M

Total cash per share (mrq)

5.81

Total debt (mrq)

254.59M

Total Debt/Equity (mrq)

37.36

Current ratio (mrq)

1.32K%

Book value per share (mrq)

5.19

Cash flow

Cash flow statement

27.27M

Levered free cash flow (LFCF)

12.50M